Rassaf Tienush, Kleinbongard Petra, Kelm Malte
University Hospital Aachen, Department of Cardiology and Pulmonary Diseases, Aachen, Germany.
Kidney Blood Press Res. 2005;28(5-6):341-8. doi: 10.1159/000090188. Epub 2006 Mar 7.
Nitric oxide (NO) generated from L-arginine by NO synthases in the endothelium and in other cells plays a central role in several aspects of vascular biology and has been linked to many regulatory functions in mammalian cells. Whereas for a long time the signaling actions of NO in the vasculature have been thought to be short-lived as a result of the rapid reaction of NO with hemoglobin, recent studies changed the biochemical thinking of NO. NO is not anymore the paracrine agent with only local effects, but, like a hormone, it disseminates throughout the body. Thus, a circulating pool of NO exists, opening new considerable pharmacological and therapeutical avenues in the diagnosis and therapy of cardiovascular diseases. In this review we briefly discuss the major routes of NO metabolism and transport in the mammalian circulation, considering plasma, red blood cell and tissue compartments separately, with a special focus on the implication of the circulating NO pool in clinical research.
一氧化氮合酶在内皮细胞和其他细胞中由L-精氨酸生成的一氧化氮(NO)在血管生物学的多个方面发挥着核心作用,并与哺乳动物细胞中的许多调节功能相关。长期以来,由于NO与血红蛋白的快速反应,人们一直认为NO在脉管系统中的信号作用是短暂的,但最近的研究改变了对NO的生化认识。NO不再仅仅是一种具有局部作用的旁分泌因子,而是像激素一样在全身扩散。因此,存在一个循环的NO池,为心血管疾病的诊断和治疗开辟了新的重要药理学和治疗途径。在本综述中,我们分别考虑血浆、红细胞和组织区室,简要讨论哺乳动物循环中NO代谢和运输的主要途径,特别关注循环NO池在临床研究中的意义。